A1338 - Triacylglycerol lipase from Komagataella phaffii expressing a triacylglycerol lipase from Yarrowia lipolytica as a processing aid

This application seeks to permit triacylglycerol lipase sourced from Komagataella phaffii containing the enzyme gene from Yarrowia lipolytica as a processing aid, for use in dairy and dairy analogue products

Page last updated: 16 September 2025

FSANZ contributes to productivity agenda

FSANZ is actively supporting the Australian Government’s productivity agenda.

We joined 30 regulators and 8 portfolio agencies in putting forward new ideas to improve regulation and reduce compliance burdens.

More than 400 ideas and 150 actions intended to boost productivity have been identified by regulators across the Australian Government.

Regulators and standards bodies like FSANZ play a critical role in supporting Australia’s productivity by effectively managing risk, enabling innovation and ensuring consumer protections.

Page last updated: 10 September 2025

Update to cost recovery fees

FSANZ will update the fees charged under our cost recovery arrangements from 1 October 2025. This ensures our framework remains transparent and reflects the actual costs of delivering regulatory services.

For 2025–26, fees will increase by an average of 4.5% compared to 2024–25. The increase ensures FSANZ recovers the true costs of processing applications in line with the Australian Government Charging Framework.

A revised Cost Recovery Implementation Statement will be available on our website from 1 October 2025.

Page last updated: 10 September 2025

A1340 - 2'-FL from GM Escherichia coli BL21 (gene donor: Akkermansia muciniphila) for use as a nutritive substance in infant formula products

This application seeks to permit GM Escherichia coli BL21 (gene donor: Akkermansia muciniphila) for the production of 2′-FL for use as a nutritive substance in infant formula products.

Page last updated: 23 September 2025

A1339 - 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL from GM Escherichia coli BL21 for use as nutritive substances in infant formula products

This application seeks to permit the voluntary use of 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL, alone or in combination, as nutritive substances in infant formula products. The nutritive substance ingredients are derived from various genetically modified Escherichia coli BL21 strains.

Page last updated: 2 October 2025
Subscribe to